Estimation of a possible tumorigenic risk of styrene from daily intake via food and ambient air

Toxicology Letters

Volumn 126, Issue 1, 2002, Pages 1-18

  Filser, Johannes G ^a   Kessler, Winfried ^a   Csanády, György A ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Food; Human; Inhalation exposure; Mouse; Oral intake; Physiological toxicokinetic model; Rat; Rodent bioassay; Species extrapolation; Styrene; Styrene 7,8 oxide; Toxicokinetics; Tumorigenic risk

Indexed keywords

STYRENE; STYRENE OXIDE;

AMBIENT AIR; ARTICLE; BIOASSAY; BLOOD ANALYSIS; BLOOD LEVEL; CALCULATION; CANCER RISK; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; GENOTOXICITY; HUMAN; LIFESPAN; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG PARENCHYMA; METABOLITE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SYSTEMIC DISEASE; TISSUE INJURY; TOXICOKINETICS;

ADULT; AIR POLLUTANTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; FOOD CONTAMINATION; HUMANS; LUNG NEOPLASMS; MALE; MICE; MODELS, BIOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; STYRENE;

ANIMALIA; RODENTIA;

EID: 0037021810     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00420-9     Document Type: Article

References (82)

1. Correlation between carcinogenic potency of chemicals in animals and humans
2. The carcinogenic assessment group of the U.S. Environmental Protection Agency, 'Quantitative Approaches in use to Assess Cancer Risk'
3. Thiol depletion induces apoptosis in cultured lung fibroblasts
4. Chronic toxicity and three-generation reproduction study of styrene monomer in the drinking water of rats
5. Activation of styrene to styrene oxide in hepatocytes and subcellular fractions of rat liver
6. Quantification of DNA adducts formed in liver, lungs, and isolated lung cells of rats and mice exposed to (14)C-styrene by nose-only inhalation
7. Reproducibility of carcinogenic potencies estimated in different rodent species. Methylene chloride: A useful example
8. Hepatic and extrahepatic formation and hydratation of styrene oxide in vitro in animals of different species and sex
9. Covalent binding of styrene to DNA in rat and mouse
10. Metabolism of styrene by human liver and lung
11. Effects of inducers and inhibitors on the microsomal metabolism of styrene to styrene oxide in mice
12. Metabolism of styrene oxide to styrene glycol by mouse liver and lung
13. Spontaneous neoplasm in B6C3F1 mice
14. Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and mice
15. Fundamental carcinogenic processes and their implications for low dose risk assessment
16. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks
17. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks
18. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man
19. A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: Formation of 2-hydroxyethyl adducts with hemoglobin and DNA
20. Depletion of pulmonary glutathione in mouse and rat caused by inhalation of styrene
21. Evaluation of genetic risk of alkylating agents: Tissue doses in the mouse from air contaminated with ethylene oxide
22. Species-specific pharmacokinetics of styrene in rat and mouse
23. Different approaches to estimate the carcinogenic risk of styrene based on animal studies
24. Toxicokinetics of inhaled propylene in mouse, rat, and human
25. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver
26. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
27. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-kappaB (RelA)-selective targeting
28. Wichtige gifte und vergiftungen
29. Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation
30. Styrene oxide in blood, hemoglobin adducts, and urinary metabolites in human volunteers exposed to (13)C(8)-styrene vapors
31. Direct determination of styrene-7,8-oxide in blood by gas chromatography with flame ionization detection
32. Pharmakokinetik von styrol-7,8-oxid bei maus und ratte
33. Effect of dosing vehicles on the pharmacokinetics of orally administered carbon tetrachloride in rats
34. Cancer mortality in a historical cohort study of workers exposed to styrene
35. Styrene-7,8-oxide in blood of workers exposed to styrene
36. Determination of styrene-7,8-oxide in whole rat blood by gas chromatography-mass spectrometry
37. Metabolism and toxicity of styrene
38. A model for estimating the daily dietary intake of a substance from food-contact articles: Styrene from polystyrene food-contact polymers
39. Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide
40. Occurance of styrene-7,8-oxide and styrene glycol in mouse after administration of styrene
41. Natural occurrence and routes of formation of styrene in food
42. Quantities of styrene in selected food products
43. Experimental contributions in identifying brain potential carcinogens in the petrochemical industry
44. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human
45. Styrene inhalation toxicity studies in mice. II. Sex differences in susceptibility of B6C3F1 mice
46. Styrene inhalation toxicity studies in mice. III. Strain differences in susceptibility
47. Mouse liver and lung glutathione S-epoxide transferase: Effects of phenobarbital and 3-methylcholantrene administration
48. Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450
49. CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively
50. Metabolism of styrene and racemic styrene-7,8-oxide in microsomes and cytosol of lung obtained from mouse, rat and human
51. A radiometric assay for hepatic epoxide hydrase activity with [7-3H] styrene oxide
52. 6-position of guanine
53. Tissue and species differences in enzymes of epoxide metabolism
54. Tissue distribution of drug-metabolizing enzymes in humans
55. Evidence for DNA and protein binding by styrene and styrene oxide
56. Effects of long-term oral administration of styrene to mice and rats
57. A carcinogenicity study of styrene-7,8-oxide in rats
58. Oxidative stress and regulation of glutathione in lung inflammation
59. Glutathione redox system in oxidative lung injury
60. Perinatal development of cytochrome P-450, cytochrome C reductase, aryl hydrocarbon hydroxylase, styrene monooxygenase, and styrene epoxide hydrolase in rabbit liver microsomes and nuclei
61. Microsomal styrene mono-oxygenase and styrene epoxide hydrase activities in rats
62. Estimation of human exposure to styrene and ethylbenzene
63. Modeling and risk assessment of carcinogenic dose-response
64. Styrene oxidation to styrene oxide in human erythrocytes is catalyzed by oxyhemoglobin
65. Metabolism and mutagenicity of styrene
66. Metabolism of styrene-7,8-oxide in human liver in vitro: Interindividual variation and stereochemistry
67. Quantitative analysis of styrene monomer in polystyrene and foods including some preliminary studies of the uptake and pharmacodynamics of the monomer in rats
68. Determination of sample size
69. Comparison of styrene-7,8-oxide adducts formed via reaction with cysteine, N-terminal valine and carboxylic acid residues in human, mouse and rat hemoglobin